NYSE:OLN
NYSE:OLNChemicals

Is Olin (OLN) Exposing a Deeper Reliability Question With Its Weaker Q4 EBITDA Outlook?

Olin Corporation has recently cut its fourth quarter 2025 outlook, now expecting adjusted EBITDA of about US$67 million after operational issues at its Freeport, Texas chlor-alkali and vinyls facility and softer pipeline chlorine demand. This guidance revision highlights how operational reliability at key sites and demand volatility in core chlor-alkali markets can quickly influence Olin’s earnings profile. We’ll now examine how this weaker Q4 EBITDA guidance, driven largely by Freeport...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

How Varegacestat Phase 3 Results and NDA Plans Could Shape Immunome’s (IMNM) Late-Stage Strategy

Immunome recently granted stock options to three new hires under its 2024 Inducement Plan and highlighted strong Phase 3 RINGSIDE data for its lead cancer drug candidate, varegacestat, while also scheduling a presentation at the 44th Annual J.P. Morgan Healthcare Conference. Together, the positive clinical results, upcoming New Drug Application plans for varegacestat, and new equity-based hiring incentives underscore Immunome’s efforts to build a pipeline and team around its late-stage...
NYSE:MLM
NYSE:MLMBasic Materials

Is Martin Marietta Materials (MLM) Pricing Too Rich After Strong Multi‑Year Share Gains?

If you are wondering whether Martin Marietta Materials is priced attractively right now, the key question is how its current share price lines up against what you think the business is worth. The stock last closed at US$638.11, with returns of 2.5% over 7 days, 4.3% over 30 days, 0.6% year to date, 24.1% over 1 year, 84.8% over 3 years and 117.4% over 5 years. This naturally raises questions about the balance between opportunity and risk at today’s level. Recent attention on US...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Is Amphastar Pharmaceuticals (AMPH) Attractively Priced After Recent Share Price Weakness?

If you are wondering whether Amphastar Pharmaceuticals' current share price reflects its true worth, you are not alone. This article is designed to help you assess that. The stock last closed at US$27.74, with returns of 3.6% over the past week, 8.1% over the past month, 4.8% year to date and a 24.3% decline over the past year, alongside a 44.0% gain over five years. Recent attention on Amphastar Pharmaceuticals has been shaped by ongoing discussions around its product portfolio and position...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

A Look At Star Bulk Carriers (SBLK) Valuation After Recent Share Price Momentum

Star Bulk Carriers (SBLK) has been drawing attention after recent share price moves, with the stock closing at US$20.75. For investors, that price now sits against the backdrop of the company’s current profitability and fleet scale. See our latest analysis for Star Bulk Carriers. The recent share price return data points to building momentum, with a 1 day move of 1.17% and a 90 day share price return of 23.59%. The 1 year total shareholder return of 42.03% and 5 year total shareholder return...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Electric Vehicles Update - Wireless Charging Innovations Propel Sustainable Urban Mobility

Recent developments in electric vehicle (EV) charging technology have been highlighted by Charging Robotics Inc.'s progress in enhancing wireless charging infrastructure for automated parking facilities. A notable collaboration between Charging Robotics and Parking Design Ltd. has seen an expanded purchase order for wireless systems, underlining the increasing demand for such solutions. This advancement promises to address challenges related to manual cable connections in automated...